In Case You Haven't Heard…

{"title":"In Case You Haven't Heard…","authors":"","doi":"10.1002/adaw.334295","DOIUrl":null,"url":null,"abstract":"<p>We asked Chinazo Cunningham, M.D., director of New York's OASAS, if she thinks the federal methadone regulations go far enough, or if she would like to see OTPs have even fewer rules. In an exclusive interview, she told <i>ADAW</i> the changes are “supported by data,” and data is where Cunningham is headed. “It will be really important to see how [the changes] impact access to methadone treatment and outcomes. Clinical judgement is obviously involved,” she said. But OASAS is monitoring and “working with programs to make sure they understand the regulatory changes.” What OASAS wants to know: how many people are coming into treatment, and if they're being retained in treatment.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"36 40","pages":"8"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.334295","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We asked Chinazo Cunningham, M.D., director of New York's OASAS, if she thinks the federal methadone regulations go far enough, or if she would like to see OTPs have even fewer rules. In an exclusive interview, she told ADAW the changes are “supported by data,” and data is where Cunningham is headed. “It will be really important to see how [the changes] impact access to methadone treatment and outcomes. Clinical judgement is obviously involved,” she said. But OASAS is monitoring and “working with programs to make sure they understand the regulatory changes.” What OASAS wants to know: how many people are coming into treatment, and if they're being retained in treatment.

如果您还没听说...
我们向纽约 OASAS 主任、医学博士 Chinazo Cunningham 询问,她是否认为联邦美沙酮法规已经走得足够远,或者她是否希望看到 OTPs 有更少的规定。在一次独家采访中,她告诉 ADAW,这些变化 "有数据支持",而数据正是坎宁安的方向。"看看[这些变化]对美沙酮治疗的获得性和结果有何影响将非常重要。她说:"这显然涉及临床判断。但 OASAS 正在进行监测,并 "与各项目合作,确保他们了解监管方面的变化"。OAS 想知道的是:有多少人接受治疗,以及他们是否继续接受治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信